INO
Inovio Pharmaceuticals, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C-
Company Profile
CEO
Jacqueline E. Shea
IPO Date
1998-12-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Inovio Pharmaceuticals, Inc.
CEO
Jacqueline E. Shea
IPO Date
1998-12-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| $0.00 |
| 21 May 2026 | KIES PETER | CFO | A-Award | Acquired | 39,760 | $1.73 |
| 21 May 2026 | KIES PETER | CFO | A-Award | Acquired | 32,480 | $0.00 |
| 21 May 2026 | Shea Jacqueline Elizabeth | director, officer: Chief Executive Officer | M-Exempt | Acquired | 28,296 | $0.00 |
| 21 May 2026 | Shea Jacqueline Elizabeth | director, officer: Chief Executive Officer | F-InKind | Disposed | 12,306 | $1.23 |
| 21 May 2026 | Shea Jacqueline Elizabeth | director, officer: Chief Executive Officer | M-Exempt | Disposed | 28,296 | $0.00 |
| 21 May 2026 | Shea Jacqueline Elizabeth | director, officer: Chief Executive Officer | A-Award | Acquired | 123,760 | $1.73 |
| 21 May 2026 | Shea Jacqueline Elizabeth | director, officer: Chief Executive Officer | A-Award | Acquired | 100,240 | $0.00 |
| 21 May 2026 | YARNO WENDY L | director | A-Award | Acquired | 41,800 | $1.23 |